Jounce Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Jounce Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2022.
  • Jounce Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $8.6M, a 27.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $8.6M -$3.28M -27.6% Dec 31, 2022 10-K/A 2023-04-28
Q3 2022 $9.44M -$3.2M -25.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $10.3M -$3.13M -23.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $11.1M -$3.06M -21.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $11.9M -$2.98M -20.1% Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 $12.6M -$2.92M -18.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $13.4M -$2.86M -17.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $14.1M -$2.8M -16.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $14.9M -$2.76M -15.7% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $15.6M -$2.7M -14.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $16.3M -$2.65M -14% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $16.9M -$2.59M -13.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $17.6M -$2.54M -12.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $18.3M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $18.9M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $19.5M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $20.2M Jan 1, 2019 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.